For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The North America cardiovascular surgical devices market is expected to grab the highest market share by the end of the forecast period of 2017-2025 by collecting approximately $45415 million.
The Canadian hospitals are well equipped to provide a state-of-the-art treatment due to the increasing adoption of latest technology. This is complemented by the US healthcare sector which comprises of the finest hospitals and clinics for heart-related procedures. The rising demand for MI procedures, growing elderly population increasing cases of cardiac disorders, various technological advancements, and the well-disposed reimbursement policies are few of the key drivers for this market. The market is mainly segmented according to the end-users and product. Currently, surgeries hold the highest market share in terms of product for the cardiovascular surgical device market.
Atrium Medical Corp, Boston Scientific Corporation, Johnson and Johnson, Toshiba Medical Systems Corporation, GE Healthcare, Abbott Inc, Medtronic Plc, Cook Medical Inc and others are the companies currently dominating the North American market.